Bears are Losing Control Over Mesoblast Limited (MESO), Here's Why It's a 'Buy' Now — Negative
MESO Zacks Investment Research — November 10, 2025After losing some value lately, a hammer chart pattern has been formed for Mesoblast Limited (MESO), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
How Much Upside is Left in Alto Neuroscience, Inc. (ANRO)? Wall Street Analysts Think 61.99% — Positive
ANRO Zacks Investment Research — November 10, 2025The consensus price target hints at a 62% upside potential for Alto Neuroscience, Inc. (ANRO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? — Neutral
MGNX Zacks Investment Research — November 10, 2025After losing some value lately, a hammer chart pattern has been formed for MacroGenics (MGNX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Does Onestream (OS) Have the Potential to Rally 25.9% as Wall Street Analysts Expect? — Positive
OS Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 25.9% in Onestream (OS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher — Neutral
PALI Zacks Investment Research — November 10, 2025After losing some value lately, a hammer chart pattern has been formed for Palisade Bio (PALI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade — Positive
KIDS Zacks Investment Research — November 10, 2025The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Does Chime Financial, Inc. (CHYM) Have the Potential to Rally 52.06% as Wall Street Analysts Expect? — Positive
CHYM Zacks Investment Research — November 10, 2025The consensus price target hints at a 52.1% upside potential for Chime Financial, Inc. (CHYM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? — Positive
KROS Zacks Investment Research — November 10, 2025The consensus price target hints at a 42.8% upside potential for Keros Therapeutics (KROS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect? — Positive
PHAR Zacks Investment Research — November 10, 2025The mean of analysts' price targets for Pharming Group (PHAR) points to a 100.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe PRA Group (PRAA) Could Rally 53.69%: Here's is How to Trade — Positive
PRAA Zacks Investment Research — November 10, 2025The mean of analysts' price targets for PRA Group (PRAA) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See a 75.15% Upside in Orion Energy Systems (OESX): Can the Stock Really Move This High? — Positive
OESX Zacks Investment Research — November 10, 2025The consensus price target hints at a 75.2% upside potential for Orion Energy Systems (OESX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 35.5% Upside in SkyWest (SKYW): Here's What You Should Know — Positive
SKYW Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 35.5% in SkyWest (SKYW). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now — Positive
SDGR Zacks Investment Research — November 10, 2025Schrodinger (SDGR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Wall Street Analysts Think Ultra Clean (UCTT) Could Surge 34.31%: Read This Before Placing a Bet — Positive
UCTT Zacks Investment Research — November 10, 2025The mean of analysts' price targets for Ultra Clean (UCTT) points to a 34.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Vericel (VCEL) Could Rally 39.42%: Here's is How to Trade — Positive
VCEL Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Believe Waystar (WAY) Could Rally 38.21%: Here's is How to Trade — Positive
WAY Zacks Investment Research — November 10, 2025The mean of analysts' price targets for Waystar (WAY) points to a 38.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See a 26.85% Upside in Controladora Vuela (VLRS): Can the Stock Really Move This High? — Positive
VLRS Zacks Investment Research — November 10, 2025The consensus price target hints at a 26.9% upside potential for Controladora Vuela (VLRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Think Slide Insurance Holdings, Inc. (SLDE) Could Surge 33.73%: Read This Before Placing a Bet — Positive
SLDE Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 33.7% in Slide Insurance Holdings, Inc. (SLDE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Crexendo (CXDO) Have the Potential to Rally 33.63% as Wall Street Analysts Expect? — Positive
CXDO Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 33.6% in Crexendo (CXDO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts See a 50.76% Upside in GRINDR INC (GRND): Can the Stock Really Move This High? — Positive
GRND Zacks Investment Research — November 10, 2025The mean of analysts' price targets for GRINDR INC (GRND) points to a 50.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
